Budget Amount *help |
¥5,200,000 (Direct Cost: ¥4,000,000、Indirect Cost: ¥1,200,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
|
Outline of Final Research Achievements |
A-beta is known as a most important molecule of Alzheimer's disease (AD) pathogenesis. We tried to identify a new modulator of gamma-secretase which is the final cutting enzyme of the A-beta production using in vivo crosslink method. As a result, unknown molecule GL was identified as a immunoprecipitant with both presnilin-1 and aph-1 antibodies. It is indicated that GL binds to other gamma-secretase components, and attenuation of GL expression by siRNA decrease A-beta production. These results suggest that regulation of GL expression might be a new therapeutic target for AD prevention or inhibition of its development.
|